Charles Schwab’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,087,730
Closed -$111M 3135
2014
Q4
$111M Buy
1,087,730
+53,476
+5% +$5.13M 0.17% 123
2014
Q3
$89.5M Sell
1,034,254
-9,166
-0.9% -$812K 0.15% 140
2014
Q2
$94.1M Sell
1,043,420
-55,051
-5% -$4.12M 0.16% 130
2014
Q1
$80.9M Sell
1,098,471
-225,218
-17% -$15.7M 0.15% 141
2013
Q4
$90.1M Sell
1,323,689
-221,981
-14% -$14.4M 0.17% 121
2013
Q3
$94.4M Sell
1,545,670
-175,027
-10% -$10.7M 0.19% 114
2013
Q2
$87.8M Buy
+1,720,697
New +$99.5M 0.2% 110

Charles Schwab's COV Position: Q1 2015 in Review

Charles Schwab sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 1,087,730 shares — an estimated $111M sold.

Charles Schwab first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $111M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Charles Schwab reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Charles Schwab sold 1,087,730 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $111M.
  • Charles Schwab first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Charles Schwab's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $111M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Charles Schwab's 13F filing for Q1 2015, filed 14 May 2015.